SERES THERAPEUTICS INC (MCRB:NASDAQ)
$8.44 -0.06 (-0.7059%)
Analysed SERES THERAPEUTICS INC (MCRB:NASDAQ) News Sources
Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
20-04-2026
yahoo.com
Seres Therapeutics to Present at CARB-X Investor Day
09-04-2026
yahoo.com
Seres Therapeutics: Q4 Earnings Snapshot
12-03-2026
yahoo.com
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
12-03-2026
yahoo.com
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
02-03-2026
yahoo.com
Sector Update: Health Care Stocks Rise Late Afternoon
12-02-2026
yahoo.com
Seres to lay off staff, pause top program in latest reboot
12-02-2026
biopharmadive.com
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases
12-02-2026
yahoo.com
Particles for Humanity Appoints Marcus Chapman as Senior Vice President and Head of Finance
13-01-2026
yahoo.com
Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy
06-01-2026
yahoo.com
What is the current price of SERES THERAPEUTICS INC (MCRB:NASDAQ)?
The current price of SERES THERAPEUTICS INC (MCRB:NASDAQ) is $8.44.
SERES THERAPEUTICS INC (MCRB:NASDAQ) absolute price change since previous trading day?
The absolute price change of SERES THERAPEUTICS INC (MCRB:NASDAQ) since the previous trading day is $-0.06.
SERES THERAPEUTICS INC (MCRB:NASDAQ) percentage price change since previous trading day?
The percentage price change of SERES THERAPEUTICS INC (MCRB:NASDAQ) since the previous trading day is -0.7059%.
What is the most recent average sentiment score for SERES THERAPEUTICS INC (MCRB:NASDAQ)?
The most recent average sentiment score for SERES THERAPEUTICS INC (MCRB:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for SERES THERAPEUTICS INC (MCRB:NASDAQ)?
The most recent sentiment for SERES THERAPEUTICS INC (MCRB:NASDAQ) is .
SEC-8K** Filing Available For SERES THERAPEUTICS INC (MCRB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.